In this week’s episode, Anna Megalakakis steps behind the mic to bring you a fast-paced and insightful roundup of the biggest developments across Australia’s life sciences sector. From blockbuster pharma shifts and cutting-edge medtech launches to biotech investment momentum and major leadership movements, this episode unpacks what matters — and why.

Anna also shares the latest from ARCS, including highlights from the HBA Sydney anniversary event, updates on the National Clinical Trials Governance Framework consultations, and fresh opportunities to get involved in the 2026 ARCS Annual Conference and the newly expanded 2025 Clinical Summit. Plus, hear about ARCS’ brand-new Enterprise Partnership model, offering organisations a powerful way to invest in their people.

In this episode:

• Pharma: Tirzepatide’s global rise, PBS expansions, and shifting clinical trial landscapes.

• Medtech: AI-powered imaging tech, next-gen valves, and long-term innovation partnerships.

• Biotech & Investment: Capital milestones, regulatory progress, and clinical breakthroughs.

• People Movement: Key promotions, awards, and leadership shifts across the sector.

• Partner With ARCS: How enterprise memberships can elevate your workforce and brand.

Whether you work in clinical trials, regulatory affairs, medical affairs, biotech, medtech, policy, or beyond — this episode gives you the insights you need to stay ahead.

Listen now and stay connected to the news shaping Australia’s life sciences future. And if you haven’t already — now’s the perfect time to join ARCS Australia and be part of the country’s largest professional community in our sector.